Daily Management Review
Business & Finance
Bullion Strengthens as Currency and Bond Market Shifts Reinforce Gold’s Monetary Appeal

Bullion Strengthens as Currency and Bond Market Shifts Reinforce Gold’s Monetary Appeal

Gold’s advance during periods when the U.S. dollar softens and Treasury yields retreat is not a coincidence of daily trading. It reflects a deeper, structural relationship between bullion and the global monetary system. When investors sense that economic momentum may cool and interest rates could...
India Reinforces E-Cigarette Prohibition as Public Health Doctrine Overrides Global Tobacco Pressure

India Reinforces E-Cigarette Prohibition as Public Health Doctrine Overrides Global Tobacco Pressure

India’s decision to retain its sweeping ban on electronic cigarettes and heated tobacco products is more than a regulatory stance; it reflects a deliberate and sustained public health doctrine that prioritizes population-level risk reduction over industry-led innovation. Since the Prohibition of...
Alphabet seeks to raise $15 billion by placing dollar bonds

Alphabet seeks to raise $15 billion by placing dollar bonds

According to Bloomberg, which is citing reliable sources, Alphabet Inc. plans to raise $15 billion by issuing dollar-denominated bonds. According to these sources, the company intends to offer seven different groups of bonds for sale.  The first estimate for the interest rates on the...
Petrobras, TotalEnergies acquire 42.5% stake in offshore oil exploration project in Namibia

Petrobras, TotalEnergies acquire 42.5% stake in offshore oil exploration project in Namibia

Brazil's Petrobras and France's TotalEnergies each obtained a 42.5% share in an offshore oil exploration project in Namibia, according to an announcement by Petrobras. The stakes were obtained from Eight Offshore Investment Holdings and Maravilla Oil & Gas. TotalEnergies will become the project...
Redefining the Core SUV: Why Toyota Chose Tokyo to Debut the All-New RAV4

Redefining the Core SUV: Why Toyota Chose Tokyo to Debut the All-New RAV4

Toyota Motor’s decision to unveil the all-new RAV4 in Tokyo is far more than a routine model refresh. It represents a carefully timed strategic statement about where the world’s largest automaker sees the future of mass-market mobility, and how it intends to defend and extend its leadership at a...
Localisation as Leverage: How BYD Is Rebuilding Its Brazil Strategy to Secure Long-Term Market Leadership

Localisation as Leverage: How BYD Is Rebuilding Its Brazil Strategy to Secure Long-Term Market Leadership

BYD’s expansion in Brazil is entering a decisive second phase, one that shifts the company’s narrative from rapid market entry to structural dominance. After initially relying on imported kits to seed volumes and capture early demand, the Chinese automaker is now repositioning its Brazilian...
Novo Nordisk shares plunge 20% on weak sales outlook

Novo Nordisk shares plunge 20% on weak sales outlook

Shares of the pharmaceutical company Novo Nordisk dropped by 19.5% in trading on the Copenhagen stock exchange, reaching a low of 296 Danish kroner, which is approximately $46.80, according to the latest trading data. After Novo presented its 2026 forecast, the stock price dropped significantly....
Glencore may sell 40% of its copper assets in DR Congo to Orion Consortium

Glencore may sell 40% of its copper assets in DR Congo to Orion Consortium

Glencore, which is one of the biggest diversified mining companies globally, and Orion Critical Mineral Consortium, a company supported by the US government, have signed a memorandum of understanding about the possible purchase of a 40% share in Glencore's copper operations in the Democratic...
SpaceX nearing merger with xAI

SpaceX nearing merger with xAI

According to Bloomberg, citing unnamed sources, Elon Musk's American company SpaceX is currently engaged in advanced discussions about merging with his artificial intelligence startup, xAI. According to sources, the companies have notified certain investors about these plans.  The deal might...
AstraZeneca may pay CSPC up to $18.5 billion for diabetes and obesity drugs

AstraZeneca may pay CSPC up to $18.5 billion for diabetes and obesity drugs

British pharmaceutical company AstraZeneca will receive the rights to experimental drugs from Chinese CSPC Pharmaceuticals for diabetes and obesity in a deal worth up to $18.5 billion. AstraZeneca will pay $1.2 billion immediately, up to $3.5 billion if it receives the necessary regulatory...
1 2 3 4 5 » ... 422